Back to Journals ClinicoEconomics and Outcomes Research Volume 18 Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective Authors Torre E , Di Matteo S, Martinotti C , Bruno GM , Cabrino A, Fogliati EL, Giusti A, Barbieri M, Bottaro LC, Colombo GL Received 10 December 2025 Accepted for publication 28 March 2026 Published 1 May 2026 Volume 2026:18 585328 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Samer Hamidi Enrico Torre, 1 Sergio Di Matteo, 2 Chiara Martinotti, 2 Giacomo Matteo Bruno, 3 Alessandro Cabrino, 2 Emma Lucia Fogliati, 2 Andrea Giusti, 4 Marco Barbieri, 5 Luigi Carlo Bottaro, 6 Giorgio Lorenzo Colombo 3 1 Diabetology and Metabolic Diseases Unit, ASL3 Genoa, Genoa, Italy
Many of ALCARs benefits are attributed to its ability to activate AMPK , an enzyme that regulates cellular energy balance and metabolic processes
Thus, variety not only enables individuality, it also greatly increases the likelihood of providing cells with the vast arrays of primary and secondary compounds essential for their nutrition and health
In my Year of Health, I learned that small steps the microhabits, the tiny tweaks really added up to big results
Serious reactions are uncommon, and a consultation helps identify anyone who should hold off or be monitored more closely
Can Mounjaro cause sulfur burps, and how can they be managed
